These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 35514987)

  • 1. Interleukin-17 Links Inflammatory Cross-Talks Between Comorbid Psoriasis and Atherosclerosis.
    Wang Y; Zang J; Liu C; Yan Z; Shi D
    Front Immunol; 2022; 13():835671. PubMed ID: 35514987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-17 Pathway Members as Potential Biomarkers of Effective Systemic Treatment and Cardiovascular Disease in Patients with Moderate-to-Severe Psoriasis.
    Wang X; Kaiser H; Kvist-Hansen A; McCauley BD; Skov L; Hansen PR; Becker C
    Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic profiling reveals interleukin-17A monoclonal antibody treatment ameliorate lipids metabolism with the potentiality to reduce cardiovascular risk in psoriasis patients.
    Cao H; Su S; Yang Q; Le Y; Chen L; Hu M; Guo X; Zheng J; Li X; Yu Y
    Lipids Health Dis; 2021 Feb; 20(1):16. PubMed ID: 33602246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Treatment with IL-17/IL-23 Inhibitors on Subclinical Atherosclerosis in Patients with Plaque Psoriasis and/or Psoriatic Arthritis: A Systematic Review.
    Tsiogka A; Gregoriou S; Stratigos A; Soulaidopoulos S; Rompoti N; Panagakis P; Papoutsaki M; Kostakis P; Kontochristopoulos G; Tsioufis K; Campanati A; Offidani A; Vlachopoulos C; Rigopoulos D
    Biomedicines; 2023 Jan; 11(2):. PubMed ID: 36830855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-17A causes depression-like symptoms via NFκB and p38MAPK signaling pathways in mice: Implications for psoriasis associated depression.
    Nadeem A; Ahmad SF; Al-Harbi NO; Fardan AS; El-Sherbeeny AM; Ibrahim KE; Attia SM
    Cytokine; 2017 Sep; 97():14-24. PubMed ID: 28570931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brodalumab: A new way to inhibit IL-17 in psoriasis.
    Facheris P; Valenti M; Pavia G; Guanziroli E; Narcisi A; Borroni RG; Costanzo A
    Dermatol Ther; 2020 May; 33(3):e13403. PubMed ID: 32285564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depression, a major comorbidity of psoriatic disease, is caused by metabolic inflammation.
    Mrowietz U; Sümbül M; Gerdes S
    J Eur Acad Dermatol Venereol; 2023 Sep; 37(9):1731-1738. PubMed ID: 37184282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3, 3'- diindolylmethane hinders IL-17A/IL-17RA interaction and mitigates imiquimod-induced psoriasiform in mice.
    Srikanth M; Rasool M
    Int Immunopharmacol; 2022 Aug; 109():108795. PubMed ID: 35487087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gradual development of psoriatic skin lesions by constitutive low-level expression of IL-17A.
    Wohn C; Brand A; van Ettinger K; Brouwers-Haspels I; Waisman A; Laman JD; Clausen BE
    Cell Immunol; 2016 Oct; 308():57-65. PubMed ID: 26653007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 17A: toward a new understanding of psoriasis pathogenesis.
    Lynde CW; Poulin Y; Vender R; Bourcier M; Khalil S
    J Am Acad Dermatol; 2014 Jul; 71(1):141-50. PubMed ID: 24655820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psoriasis: rationale for targeting interleukin-17.
    Girolomoni G; Mrowietz U; Paul C
    Br J Dermatol; 2012 Oct; 167(4):717-24. PubMed ID: 22716185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revisiting the interleukin 17 family of cytokines in psoriasis: pathogenesis and potential targets for innovative therapies.
    Brembilla NC; Boehncke WH
    Front Immunol; 2023; 14():1186455. PubMed ID: 37283755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of genetic polymorphism of interleukin-17A & interleukin-17F with susceptibility of psoriasis.
    Kaur R; Rawat AK; Kumar S; Aadil W; Akhtar T; Narang T; Chopra D
    Indian J Med Res; 2018 Oct; 148(4):422-426. PubMed ID: 30666004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosmarinic acid ameliorated psoriatic skin inflammation in mice through the novel inhibition of the interleukin-17A/interleukin-17A receptor interaction.
    Ho TY; Lo HY; Liu IC; Huang SL; Hsiang CY
    Food Funct; 2022 Jun; 13(12):6802-6812. PubMed ID: 35674182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 17 drives vascular inflammation, endothelial dysfunction, and arterial hypertension in psoriasis-like skin disease.
    Karbach S; Croxford AL; Oelze M; Schüler R; Minwegen D; Wegner J; Koukes L; Yogev N; Nikolaev A; Reißig S; Ullmann A; Knorr M; Waldner M; Neurath MF; Li H; Wu Z; Brochhausen C; Scheller J; Rose-John S; Piotrowski C; Bechmann I; Radsak M; Wild P; Daiber A; von Stebut E; Wenzel P; Waisman A; Münzel T
    Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2658-68. PubMed ID: 25341795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psoriasis and metabolic syndrome: implications for the management and treatment of psoriasis.
    Wu JJ; Kavanaugh A; Lebwohl MG; Gniadecki R; Merola JF
    J Eur Acad Dermatol Venereol; 2022 Jun; 36(6):797-806. PubMed ID: 35238067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-17 Blockade in Psoriasis: Friend or Foe in Cardiovascular Risk?
    Torres T; Raposo I; Selores M
    Am J Clin Dermatol; 2016 Apr; 17(2):107-12. PubMed ID: 26596991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
    Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
    Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptome profiling unveils the role of cholesterol in IL-17A signaling in psoriasis.
    Varshney P; Narasimhan A; Mittal S; Malik G; Sardana K; Saini N
    Sci Rep; 2016 Jan; 6():19295. PubMed ID: 26781963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin (IL)-17/IL-36 axis participates to the crosstalk between endothelial cells and keratinocytes during inflammatory skin responses.
    Mercurio L; Failla CM; Capriotti L; Scarponi C; Facchiano F; Morelli M; Rossi S; Pagnanelli G; Albanesi C; Cavani A; Madonna S
    PLoS One; 2020; 15(4):e0222969. PubMed ID: 32352958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.